La Rosa, C., Longmate, J., Lacey, S. F., Kaltcheva, T., Sharan, R., Marsano, D., . . . Zaia, J. A. (2012). Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant. Oxford University Press.
Citación estilo ChicagoLa Rosa, Corinna, et al. Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant. Oxford University Press, 2012.
Cita MLALa Rosa, Corinna, et al. Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant. Oxford University Press, 2012.
Precaución: Estas citas no son 100% exactas.